Article ID Journal Published Year Pages File Type
5829047 European Journal of Pharmacology 2013 9 Pages PDF
Abstract
GY3 increases glucose consumption and decreases lipid ccumulation in HepG2 hepatocytes and mature 3T3-L1 adipocytes through AMPK pathway. Control (CL), Metformine (Met), Rosiglitazone (Ros).232
Keywords
Related Topics
Life Sciences Neuroscience Cellular and Molecular Neuroscience
Preview
A novel indole derivative compound GY3 improves glucose and lipid metabolism via activation of AMP-activated protein kinase pathway
Authors
, , , , , , ,